Fundamentals

Valuation

Metric	Q4	Q1	Δ in %
EV/EBITDA	-2.07	31.96	32.64
Graham Fair Price	28.87	22.74	17.64
PEG	-56.09	0.36	-0.83
Price/Book	-4.33	3.24	3.39
Price/Cash Flow	343.41	186.05	41.96
Prices/Earnings	-33.64	19.64	29.59
Price/Sales	-4.75	2.74	2.87
Price/FCF	343.41	186.05	41.96
Naive Interpretation	member

01 - Valuation · Somewhat Weak

Fundamentals

Profitability

Metric	Q4	Q1	Δ in %
Gross Profit Margin	-11.05	0.28	0.31
Operating Margin	78.14	0.05	0.03
ROA	52.69	< 0.005	< 0.005
ROE	0.03	0.04	44.17
ROIC	< 0.005	0.02	237.89
Naive Interpretation	member

02 - Profitability · Not Interpreted

Fundamentals

Financial Growth

Metric	Q4	Q1	Δ in %
Debt QOQ	< 0.005	< 0.005	519.59
Dividends QOQ	0.00	0.00	0.00
EBIT QOQ	-0.62	0.92	48.14
EPS QOQ	-0.36	0.54	51.11
FCF QOQ	-0.62	-0.77	-23.87
Revenue QOQ	-0.11	0.08	-27.54
Naive Interpretation	member

03 - Financial Growth · Weak

Fundamentals

Leverage & Liquidity

Metric	Q4	Q1	Δ in %
Assets Turnover	n.A.	n.A.	n.A.
Days Inventory Outstanding (DIO)	51.39	43.24	-15.86
Days Sales Outstanding (DSO)	20.75	16.88	-18.68
Inventory Turnover	1.75	2.08	18.84
Debt/Capitalization	0.68	0.56	-18.48
Quick Ratio	0.71	0.71	0.63
Naive Interpretation	member

04 - Leverage & Liquidity · Weak

Fundamentals

Per Share Metrics

Metric	Q4	Q1	Δ in %
Book Value	21.98	23.59	7.33
Cash	22.55	22.41	-0.58
Capex	-1.11	-1.72	-54.60
Free Cash Flow	1.78	0.41	-76.84
Revenue	25.92	27.94	7.81
Naive Interpretation	member

05 - Per Share Metrics · Weak

Fundamentals

Financial Health

Metric	Q4	Q1	Δ in %
Current Ratio	0.97	1.00	3.04
Debt/Assets	n.A.	n.A.	n.A.
Debt/Equity	n.A.	n.A.	n.A.
Net Debt/EBITDA	9.38	9.22	-1.71
Naive Interpretation	Member

06 - Financial Health · Bad

Rating